American National Bank Gilead Sciences, Inc. Transaction History

American National Bank

$739 Million
Q1 2024

A detailed history of American National Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, American National Bank holds 2,759 shares of GILD stock, worth $183,721. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,759

Previous 2,824 2.3%

Holding current value

$183,721

Previous $228,000 11.4%

% of portfolio

0.03%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	SELL	$71.58 - $87.29 $4,652 - $5,673	-65 Reduced 2.3%	2,759 $202,000
Q4 2023 Feb 08, 2024	SELL	$73.27 - $83.09 $11,356 - $12,878	-155 Reduced 5.2%	2,824 $228,000
Q3 2023 Oct 10, 2023	SELL	$73.94 - $80.67 $75,270 - $82,122	-1,018 Reduced 25.47%	2,979 $223,000
Q1 2023 Apr 25, 2023	SELL	$77.31 - $88.08 $769,389 - $876,572	-9,952 Reduced 71.35%	3,997 $331,000
Q4 2022 Jan 10, 2023	SELL	$62.32 - $89.47 $46,615 - $66,923	-748 Reduced 5.09%	13,949 $1.2 Million

Q3 2022 Oct 05, 2022	SELL	$59.54 - $68.01 $26,435 - $30,196	-444 Reduced 2.93%	14,697 $907,000
Q2 2022 Jul 11, 2022	BUY	$57.72 - $65.01 $206,695 - $232,800	3,581 Added 30.98%	15,141 $936,000
Q1 2022 Apr 08, 2022	BUY	$57.92 - $72.58 $405,729 - $508,422	7,005 Added 153.79%	11,560 $687,000
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $295,528 - $335,430	4,555 New	4,555 $331,000
Q2 2020 Jul 07, 2020	SELL	$72.34 - $84.0 $22,063 - $25,620	-305 Closed	0 $0
Q4 2019 Jan 10, 2020	SELL	$61.62 - $67.78 $1.99 Million - $2.19 Million	-32,277 Reduced 99.06%	305 $20,000
Q3 2019 Oct 10, 2019	SELL	$62.51 - $69.0 $786,375 - $868,020	-12,580 Reduced 27.86%	32,582 $2.07 Million
Q2 2019 Jul 17, 2019	SELL	$61.87 - $69.38 $173,978 - $195,096	-2,812 Reduced 5.86%	45,162 $3.05 Million
Q1 2019 Apr 15, 2019	BUY	$62.53 - $70.05 $58,090 - $65,076	929 Added 1.97%	47,974 $3.12 Million
Q4 2018 Jan 11, 2019	SELL	$60.54 - $79.0 $130,948 - $170,877	-2,163 Reduced 4.4%	47,045 $2.94 Million
Q3 2018 Oct 04, 2018	BUY	$71.28 - $78.92 $638,312 - $706,728	8,955 Added 22.25%	49,208 $3.8 Million
Q2 2018 Jul 05, 2018	SELL	$64.88 - $75.68 $545,251 - $636,014	-8,404 Reduced 17.27%	40,253 $2.85 Million
Q1 2018 Apr 10, 2018	BUY	$72.84 - $88.8 $1.17 Million - $1.43 Million	16,090 Added 49.41%	48,657 $3.67 Million
Q4 2017 Jan 11, 2018	BUY	$71.15 - $83.52 $682,115 - $800,706	9,587 Added 41.72%	32,567 $2.33 Million
Q3 2017 Oct 10, 2017	BUY	$72.11 - $85.47 $1.66 Million - $1.96 Million	22,980	22,980 $1.86 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American National Bank, based on Form 13F filings with the SEC.

News

Stay updated on American National Bank with notifications on news.

Account

American National Bank Gilead Sciences, Inc. Transaction History